These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33014469)

  • 1. Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow.
    Naserifar M; Ataei M; Behzadian N; Mohammadpour AH; Dastani M; Sahebkar A; Hosseinjani H
    Int J Vasc Med; 2020; 2020():4592190. PubMed ID: 33014469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric Dimethylarginine Is Associated with the Phenomenon of Coronary Slow Flow in Patients with Nonvalvular Atrial Fibrillation.
    Du Z; Jiang W; Yu C; Lu X; Xia W
    Cardiology; 2024; 149(3):208-216. PubMed ID: 38246155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum nitric oxide synthase levels in patients with coronary slow flow based on corrected TIMI frame count.
    Shamsara J; Elyasi S; Dastani M; Behzadian N; Hosseinjani H; Ataei M; Jafari F; Akbarzadeh M; Naserifar M; Sahebkar A; Mohammadpour AH
    Arch Med Sci Atheroscler Dis; 2023; 8():e140-e145. PubMed ID: 38283932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of endothelial dysfunction and inflammation on slow coronary flow.
    Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Asymmetric Dimethylarginine with the Severity of Coronary Artery Disease: A Pilot Study.
    Goudhaman L; Raja Jagadeesan A; Sundaramoorthi S; Thotla S; Krishna Mohan S
    Rep Biochem Mol Biol; 2021 Jul; 10(2):302-306. PubMed ID: 34604419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
    Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
    J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow.
    Li M; Su H; Jiang M; Zuo Z; Su Z; Hao L; Yang J; Zhang Z; Wang H; Kong X
    Quant Imaging Med Surg; 2022 Oct; 12(10):4942-4952. PubMed ID: 36185054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
    Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M
    Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients.
    Shivkar RR; Abhang SA
    J Clin Diagn Res; 2014 Aug; 8(8):CC04-6. PubMed ID: 25302189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
    Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
    Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.
    Mangiacapra F; Conte M; Demartini C; Muller O; Delrue L; Dierickx K; Di Sciascio G; Trimarco B; De Bruyne B; Wijns W; Bartunek J; Barbato E
    Int J Cardiol; 2016 Oct; 220():629-33. PubMed ID: 27391005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease.
    Xuan C; Liu ZF; Wang Q; Guo FF; Zhang X; He GW; Lun LM
    Clin Chim Acta; 2017 Jan; 464():195-199. PubMed ID: 27884754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
    Elesber AA; Solomon H; Lennon RJ; Mathew V; Prasad A; Pumper G; Nelson RE; McConnell JP; Lerman LO; Lerman A
    Eur Heart J; 2006 Apr; 27(7):824-31. PubMed ID: 16434411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine levels in patients with coronary artery ectasia.
    Cay S; Cagirci G; Akcay M; Karakurt O; Kahraman E; Yazihan N; Canga A; Akdemir R; Aydogdu S
    Kardiol Pol; 2009 Dec; 67(12):1362-8. PubMed ID: 20054767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.